相关实验视频

Updated: Jul 2, 2025

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

针对针对特定瘤标记物的抗癌的计算设计

Aisha Naeem¹, Nighat Noureen², Shaikha Khalid Al-Naemi³

¹QU Health, Qatar University, P.O. Box 2713, Doha, Qatar. a.naeem@qu.edu.qa.

|February 22, 2024

概括

研究人员设计了针对癌症过度表达的CXCR1,DCR3和OPG受体的新型抗癌 (ACP). 在 silico 方法中确定了具有高结合亲和度的有希望的候选者,以便进一步进行实验验证.

科学领域:

在瘤学瘤学.
计算生物学计算生物学
体设计体设计

背景情况:

抗癌 (ACP) 显示出抑制癌症进展的潜力.
像CXCR1,DCR3和OPG这样的受体在各种癌症中经常过度表达,这使得它们成为有吸引力的治疗点.
用特定的酸针对这些受体可以提供一种新的抗癌策略.

研究的目的:

设计和识别新型抗癌 (ACP),使用系统的in silico方法.
针对已知在癌症中过度表达的特定受体 (CXCR1,DcR3,OPG).
评估设计的与它们的受体的结合亲和力和相互作用.

主要方法:

选择了向受体 (CXCR1,DcR3,OPG) 并确定了它们的自然配体 (IL8,TL1A,RANKL).
识别了受体和配体的相互作用残留物 (IR),以设计库.
利用AntiCP网络服务器来预测抗癌性质和对接模拟 (VEGA ZZ,Chimera) 来进行绑定效率分析.

主要成果:

确定了CXCR1-IL8 (HPKFIKELR) 的特定相互作用残留物.
基于自然连接体域的DcR3和OPG的设计和选的类.
入围的C9,C7 (CXCR1),D6,D18 (DcR3) 和P19,p16 (OPG) 通过in silico分析显示出高亲和力和强烈的相互作用.

结论:

在的方法成功地确定了潜在的抗癌,准CXCR1,DCR3和OPG.
设计的体表现出有利的结合亲和力和与各自的受体的相互作用概况.
进一步的实验验证至关重要,以确认这些新型ACP的疗效,稳定性和药物动力学特性.

关键词:

抗癌是一种抗癌.一个CXCR1的CXCR1.DcR3 DcR3 DcR3 DcR3 DcR3 DcR3 DcR3 DcR3 DcR3 DcR3 DcR3 DcR3 DcR3 同性学建模的模拟.有机天然气 (OPG) 是一种天然气.

更多相关视频

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...